SAN DIEGO, January  27, 2011 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, announced today that CEO Dr. Marcus Hompesch is an invited speaker at the Ramanbhai Foundation 5th International Symposium and ISCR’s 4th Annual Clinical Research Conference in February. 

SAN DIEGO, November 22, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the expansion of its capabilities for cardiac safety and cardiovascular efficacy studies in the company’s early phase diabetes and obesity clinical trials.

SAN DIEGO, October 7, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the initiation of patient screening in Orange County for clinical trial eligibility at the company’s San Diego clinical facility.  

SAN DIEGO, September 15, 2010 – Profil™ Institute for Clinical Research, Inc. will present key clinical and experimental diabetes and insulin-related research at the European Association of the Study of Diabetes (EASD) 46th Annual Meeting being held September 20 – 24 in Stockholm, Sweden.  Profil Institute’s presence as a contributor of scientific presentations emphasizes the company’s position as a specialized contract research institute optimizing early phase diabetes, obesity and cardiometabolic drug development.

SAN DIEGO, July 8, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today that Dr. Marcus Hompesch, the company’s President and CEO, will serve as San Diego’s 2010 Corporate Chairman for Step Out: Walk to Fight Diabetes, the American Diabetes Association’s (ADA) largest fund-raising event.

SAN DIEGO, June 22, 2010 – Profil™ Institute for Clinical Research, Inc. will present the company’s key clinical and experimental diabetes and insulin-related research at the American Diabetes Association 70th Scientific Sessions 2010 Annual Meeting being held June 25 – 29 in Orlando, Fla.  Profil’s presence as a contributor of scientific presentations emphasizes and confirms the unique role the institute plays as a specialized contract research institute in the early phase diabetes drug development process.

SAN DIEGO, June 17, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the appointment of Prof. Dr. Lutz Heinemann as Director of Scientific Services and Robert J. Schott, MD, MPH, FACC as Director of Cardiometabolic Research. Prof. Dr. Heinemann will oversee the scientific aspects of Profil's integrated approach from clinical trial protocol design to the publication of study results. Dr. Schott will oversee the design and execution of cardiometabolic and cardiac safety studies for the company’s biopharmaceutical clients.

"We couldn’t be more pleased to have Drs. Heinemann and Schott join the Profil scientific management team where they will have a direct impact on finding better treatments for diabetes and obesity," said Dr. Marcus Hompesch, Profil President and CEO.

SAN DIEGO, June 14, 2010 – Profil™ Institute for Clinical Research, Inc. (PICR) today announced that Director of Human Resources Susan Penn is a finalist for San Diego’s 3rd Annual HR Professional of the Year Awards hosted by San Diego Business Journal. Award winners will be announced at a gala event on June 17, 2010 at the Hilton San Diego Bayfront Hotel.
 

SAN DIEGO, May 12, 2010 /PRNewswire/ – Profil™ Institute for Clinical Research, Inc. (PICR) today announced that president and CEO
Dr. Marcus Hompesch is a finalist for the Ernst & Young Entrepreneur Of The Year® 2010 Award in San Diego for the second year in a row. Award winners will be announced at a gala event on June 9, 2010 at the Hyatt La Jolla Aventine.